Your session is about to expire
← Back to Search
Virtual Active Surveillance for Testicular Cancer
N/A
Waitlist Available
Led By Robert J Hamilton, MD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Men who are at least 18 years of age
Have had histologically confirmed stage 1 testicular cancer (seminoma or non-seminoma)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up december 2017 - december 2026
Awards & highlights
Study Summary
This trial is testing a new online platform to provide virtual cancer follow-up appointments, in order to reduce the cost and time commitment for patients.
Who is the study for?
This trial is for men over 18 who can understand English, have access to a digital device, and have had stage 1 testicular cancer treated with orchiectomy within the last 9 months. They should be ready to follow a strict check-up schedule. Men with metastatic disease or relapse in the first 9 months, or poor computer skills as judged by the study team cannot join.Check my eligibility
What is being tested?
The WATChmAN project is testing a web-based virtual clinic against traditional in-person visits for monitoring testicular cancer patients under active surveillance. The goal is to see if online follow-ups can improve patient satisfaction and adherence while reducing costs.See study design
What are the potential side effects?
Since this trial involves monitoring methods rather than medication, there are no direct medical side effects. However, participants may experience issues related to using technology such as privacy concerns or technical difficulties.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a man aged 18 or older.
Select...
I was diagnosed with stage 1 testicular cancer.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ december 2017 - december 2026
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~december 2017 - december 2026
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Safety and Efficacy
Secondary outcome measures
Clinic Flow Metrics
Patient Satisfaction
Physician Satisfaction
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: WATChmANExperimental Treatment1 Intervention
Patients randomized to the WATChmAN Active Surveillance arm will receive their active surveillance testicular cancer care via an online virtual clinic. Importantly, patients will follow the same surveillance schedule as patients in the standard of care arm. However, patients in the WATChmAN arm will be able to see their upcoming tests and virtual appointments online, request requisitions to perform their required testing at outside institutions, and indicate any concerns for physicians to review during the virtual visit.
Group II: Standard of CareActive Control1 Intervention
Patients randomized to the standard of care arm (in-person active surveillance) will follow the current active surveillance protocol in place at Princess Margaret Cancer Centre's Multidisciplinary Testicular Cancer Clinic. This protocol involves the same schedule of testing as the WATChmAN arm, but will require patients to come into the clinic to receive their test results (as in current practice).
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,468 Previous Clinical Trials
484,375 Total Patients Enrolled
2 Trials studying Testicular Cancer
331 Patients Enrolled for Testicular Cancer
Robert J Hamilton, MDPrincipal InvestigatorThe Princess Margaret Cancer Foundation
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- My cancer spread or came back within 9 months of starting active surveillance.I had surgery to remove a testicle due to cancer and am being closely monitored.I am a man aged 18 or older.The study team considers my computer skills or ability to follow the study plan as inadequate.I was diagnosed with stage 1 testicular cancer.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care
- Group 2: WATChmAN
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is recruitment ongoing for this research project?
"Clinicaltrials.gov reveals that this medical study is not presently open for enrollment. It was first advertised on December 15th 2017, and the last updates were made April 12th 2021; however there are 22 other clinical trials currently seeking participants."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger